Citation sources

Updated weekly. Details via Crossref
Crossref Scopus Google Scholar
23 22 Search
2025
Acetylsalicylic acid and cancer: updates on the new potential of a nature-inspired drug
Naunyn-Schmiedeberg's Archives of Pharmacology
2025
Aspirin-induced acetylation of APE1/Ref-1 enhances RAGE binding and promotes apoptosis in ovarian cancer cells
The Korean Journal of Physiology & Pharmacology
2025
Targeting DAMPs by Aspirin Inhibits Head and Neck Cancer Stem Cells and Stimulates Radio-Sensitization to Proton Therapy
Cancers
2025
Selective inhibition of aminopeptidase N by paclitaxel: Insights into enzymatic interactions with cytostatics and analgesics in cancers
International Journal of Biological Macromolecules
2025
The Value of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in the Prevention of Colorectal Cancer
Advances in Clinical Medicine
2025
Aspirin in Cancer Therapy: Pharmacology and Nanotechnology Advances
International Journal of Nanomedicine
2024
The CDK4/6 Inhibitor Palbociclib Induces Cell Senescence of High-grade Serous Ovarian Cancer Through Acetylation of p53
Biochemical Genetics
2024
Cancer-associated adipocytes in the ovarian cancer microenvironment
American Journal of Cancer Research
2024
The ZuoJinWan formula inhibits glycolysis of cisplatin resistant gastric cancer cells via p53 acetylation
Pharmacological Research - Modern Chinese Medicine
2024
Characteristics of the Antitumor Effect of Doxorubicin and Pegylated Hyaluronidase on Models of Rat Brain Tumors
Bulletin of Experimental Biology and Medicine
2024
Using aspirin to prevent and treat cancer
Inflammopharmacology
2024
Elevated Platelet Aggregation in Patients with Ovarian Cancer: More than Just Increased Platelet Count
Cancers
2024
Anti-Inflammatory Effects of Quercetin, Rutin, and Troxerutin Result From the Inhibition of NO Production and the Reduction of COX-2 Levels in RAW 264.7 Cells Treated with LPS
Applied Biochemistry and Biotechnology
2024
Drug Repositioning for Ovarian Cancer Treatment: An Update
Anti-Cancer Agents in Medicinal Chemistry
2024
BRCA Mutation in Ovarian Cancer: Implications for Screening, Diagnosis, and Preventive Measures
EMJ Oncology
2023
Friend or Foe: Regulation, Downstream Effectors of RRAD in Cancer
Biomolecules
2023
Looking at NSAIDs from a historical perspective and their current status in drug repurposing for cancer treatment and prevention
Journal of Cancer Research and Clinical Oncology
2023
The Effect of Acetylsalicylic Acid, as a Representative Non-Steroidal Anti-Inflammatory Drug, on the Activity of Myeloperoxidase
Pharmaceuticals
2022
Research on Clinical Effectiveness of Aspirin for Treating Breast Cancer and Cell Protein Biomarkers on Aspirin Treatment in Drug-Resistant Estrogen Receptor-Positive Breast Cancer Cells
Oncologie
2022
Aspirin Suppressed PD-L1 Expression through Suppressing KAT5 and Subsequently Inhibited PD-1 and PD-L1 Signaling to Attenuate OC Development
Journal of Oncology
2022
Pro-Inflammatory Signalling PRRopels Cisplatin-Induced Toxicity
International Journal of Molecular Sciences
2022
Downregulated Dual-Specificity Protein Phosphatase 1 in Ovarian Carcinoma: A Comprehensive Study With Multiple Methods
Pathology and Oncology Research
2021
Interactions of Analgesics with Cisplatin: Modulation of Anticancer Efficacy and Potential Organ Toxicity
Medicina